GRTX

Galera Therapeutics, Inc.CIK 1563577 ☆ Sign in to watch Congress trades

Open-mkt buys · 90d

—

0 trades · 0 insiders

Open-mkt sales · 90d

—

0 trades · 0 insiders

Net · 90d

Insiders on file

AI insights for GRTX PRO

XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%

AI insights for GRTX

Insider sentiment score with a plain-English explanation, conviction score on every buy, and how the stock performed 30 and 90 days after past insider buys.

Upgrade to Pro · $99/year Already Pro? Log in

Daily buy vs sell · 90 days

No data yet.

Insiders

Insider	Role	Trades	Bought	Sold	Last trade
FRIEDMAN MICHAEL R.	Director	12	$0	$0	2026-08-03
Sussman Joel F.	Chief Accounting Officer	15	$0	$203.8K	2026-08-03
Alleva Lawrence M	Director	17	$97.6K	$0	2026-08-03
Sorensen Mel	President and CEO, Director	16	$168.0K	$6.1K	2026-08-03
LOKAY KEVIN G	Director	7	$0	$0	2026-08-03
CHANG NANCY T	Director, 10% Owner	13	$535.1K	$0	2026-08-03
Opler Timothy	10% Owner	2	$0	$0	2026-05-15
Schneid Yair	10% Owner	28	$755.9K	$0	2024-04-19
West Linda	Director	12	$405.4K	$0	2023-07-01
Cunningham Emmett	Director	6	$0	$0	2023-06-14
POWELL MICHAEL	Director, 10% Owner	5	$0	$0	2023-06-14
Bachleda Mark	Chief Commercial Officer	4	$24.8K	$0	2023-03-16
Degnan Chris	Chief Financial Officer	6	$19.6K	$0	2023-03-13
Kennedy Eugene P.	Chief Medical Officer	2	$0	$0	2023-02-25
Stacey Jennifer Evans	See Remarks	3	$0	$0	2023-02-25
Beardsley Robert A	Chief Operating Officer	14	$0	$0	2023-02-25
HOLMLUND JON T	Chief Medical Officer	44	$0	$751.1K	2022-02-28
Novo Holdings A/S	10% Owner	7	$6.00M	$10.24M	2021-02-18
Fratamico Arthur	Chief Business Officer	2	$0	$0	2021-01-26
Novartis Bioventures Ltd	Other	8	$0	$8.62M	2020-06-19
NOVARTIS AG	10% Owner	11	$3.00M	$339.4K	2020-06-17
Riley Dennis	Chief Scientific Officer	1	$0	$0	2020-01-31
Clarus IV-B, L.P.	10% Owner	12	$3.00M	$0	2019-11-12
Blackstone Holdings II L.P.	10% Owner	12	$3.00M	$0	2019-11-12
HEALY JAMES	10% Owner	4	$9.00M	$0	2019-11-12
MOTT DAVID M	10% Owner	7	$5.00M	$0	2019-11-12
Fuller Jason	Director	1	$0	$0	2019-11-06
Blackstone Group Management L.L.C.	10% Owner	1	$0	$0	2019-11-06

Trade history

Insider	Role	Code	Trade	Filed	Shares	Price	Value	Owned after
FRIEDMAN MICHAEL R.	Director	D To issuer deriv	2026-08-03	2026-08-05	480	—	$0	0	SEC↗
Sussman Joel F.	Chief Accounting Officer	D To issuer deriv	2026-08-03	2026-08-05	10,000	—	$0	0	SEC↗
Alleva Lawrence M	Director	D To issuer deriv	2026-08-03	2026-08-05	240	—	$0	0	SEC↗
CHANG NANCY T	Director, 10% Owner	D To issuer deriv	2026-08-03	2026-08-05	480	—	$0	0	SEC↗
LOKAY KEVIN G	Director	D To issuer deriv	2026-08-03	2026-08-05	240	—	$0	0	SEC↗
Sorensen Mel	President and CEO	D To issuer deriv	2026-08-03	2026-08-05	30,000	—	$0	0	SEC↗
FRIEDMAN MICHAEL R.	Director	D To issuer	2026-08-03	2026-08-05	41,631	—	$0	0	SEC↗
Alleva Lawrence M	Director	D To issuer	2026-08-03	2026-08-05	40	—	$0	0	SEC↗
Alleva Lawrence M	Director	D To issuer	2026-08-03	2026-08-05	11	—	$0	0	SEC↗
CHANG NANCY T	Director, 10% Owner	D To issuer	2026-08-03	2026-08-05	47,434	—	$0	0	SEC↗
Sorensen Mel	President and CEO	D To issuer	2026-08-03	2026-08-05	975	—	$0	0	SEC↗
Sorensen Mel	President and CEO, Director	D To issuer deriv	2026-08-03	2026-08-05	30,000	—	—	0	SEC↗
Sorensen Mel	President and CEO, Director	D To issuer	2026-08-03	2026-08-05	975	—	—	0	SEC↗
LOKAY KEVIN G	Director	D To issuer deriv	2026-08-03	2026-08-05	240	—	—	0	SEC↗
Sussman Joel F.	Chief Accounting Officer	D To issuer deriv	2026-08-03	2026-08-05	10,000	—	—	0	SEC↗
FRIEDMAN MICHAEL R.	Director	D To issuer deriv	2026-08-03	2026-08-05	480	—	—	0	SEC↗
FRIEDMAN MICHAEL R.	Director	D To issuer	2026-08-03	2026-08-05	41,631	—	—	0	SEC↗
CHANG NANCY T	Director, 10% Owner	D To issuer deriv	2026-08-03	2026-08-05	480	—	—	0	SEC↗
CHANG NANCY T	Director, 10% Owner	D To issuer	2026-08-03	2026-08-05	47,434	—	—	0	SEC↗
Alleva Lawrence M	Director	D To issuer deriv	2026-08-03	2026-08-05	240	—	—	0	SEC↗
Alleva Lawrence M	Director	D To issuer	2026-08-03	2026-08-05	40	—	—	0	SEC↗
Alleva Lawrence M	Director	D To issuer	2026-08-03	2026-08-05	11	—	—	0	SEC↗
FRIEDMAN MICHAEL R.	Director	C Conversion deriv	2026-05-15	2026-08-05	2,989	—	$0	0	SEC↗
CHANG NANCY T	Director, 10% Owner	C Conversion deriv	2026-05-15	2026-08-05	661	—	$0	0	SEC↗
FRIEDMAN MICHAEL R.	Director	C Conversion	2026-05-15	2026-08-05	2,989,399	—	$0	8,326,269	SEC↗
CHANG NANCY T	Director, 10% Owner	C Conversion	2026-05-15	2026-08-05	661,309	—	$0	9,486,852	SEC↗
Opler Timothy	10% Owner	C Conversion deriv	2026-05-15	2026-05-29	20,814	—	$0	0	SEC↗
Opler Timothy	10% Owner	C Conversion	2026-05-15	2026-05-29	20,813,818	—	$0	61,029,978	SEC↗
FRIEDMAN MICHAEL R.	Director	C Conversion deriv	2026-05-15	2026-08-05	2,989	—	$0	0	SEC↗
FRIEDMAN MICHAEL R.	Director	C Conversion	2026-05-15	2026-08-05	2,989,399	—	—	8,326,269	SEC↗
CHANG NANCY T	Director, 10% Owner	C Conversion deriv	2026-05-15	2026-08-05	661	—	$0	0	SEC↗
CHANG NANCY T	Director, 10% Owner	C Conversion	2026-05-15	2026-08-05	661,309	—	—	9,486,852	SEC↗
CHANG NANCY T	Director, 10% Owner	C Conversion deriv	2026-04-07	2026-04-09	1,181	—	$0	661	SEC↗
FRIEDMAN MICHAEL R.	Director	C Conversion deriv	2026-04-07	2026-04-09	5,337	—	$0	2,989	SEC↗
CHANG NANCY T	Director, 10% Owner	C Conversion	2026-04-07	2026-04-09	1,180,611	—	$0	8,825,543	SEC↗
FRIEDMAN MICHAEL R.	Director	C Conversion	2026-04-07	2026-04-09	5,336,870	—	$0	5,336,870	SEC↗
Sorensen Mel	President and CEO	S Sale	2025-11-20	2025-11-24	70,000	$0.02	$1.4K	195,029	SEC↗
Sorensen Mel	President and CEO	A Award deriv	2025-05-01	2025-05-05	6,000,000	—	$0	6,000,000	SEC↗
Sussman Joel F.	Chief Accounting Officer	A Award deriv	2025-05-01	2025-05-05	2,000,000	—	$0	2,000,000	SEC↗
Alleva Lawrence M	Director	A Award deriv	2025-02-24	2025-02-26	48,000	—	$0	48,000	SEC↗
CHANG NANCY T	Director, 10% Owner	A Award deriv	2025-02-24	2025-02-26	96,000	—	$0	96,000	SEC↗
FRIEDMAN MICHAEL R.	Director	A Award deriv	2025-02-24	2025-02-26	96,000	—	$0	96,000	SEC↗
LOKAY KEVIN G	Director	A Award deriv	2025-02-24	2025-02-26	48,000	—	$0	48,000	SEC↗
FRIEDMAN MICHAEL R.	Director	A Award deriv	2024-12-30	2025-01-02	8,326	—	$0	8,326	SEC↗
CHANG NANCY T	Director, 10% Owner	A Award deriv	2024-12-30	2025-01-02	1,842	—	$0	1,842	SEC↗
CHANG NANCY T	Director, 10% Owner	P Buy	2024-12-30	2025-01-02	7,644,932	$0.07	$535.1K	7,644,932	SEC↗
Sorensen Mel	President and CEO	S Sale	2024-08-16	2024-08-20	67,015	$0.07	$4.7K	265,029	SEC↗
Schneid Yair	10% Owner	P Buy	2024-04-19	2024-05-01	99,371	$0.19	$18.9K	10,823,610	SEC↗
Schneid Yair	10% Owner	P Buy	2024-04-19	2024-05-01	215	$0.19	$41	10,724,239	SEC↗
Schneid Yair	10% Owner	P Buy	2024-04-19	2024-05-01	314	$0.19	$60	10,724,024	SEC↗
Schneid Yair	10% Owner	P Buy	2024-04-19	2024-05-01	100	$0.19	$19	10,723,710	SEC↗
Schneid Yair	10% Owner	P Buy	2024-04-18	2024-05-01	4,245	$0.20	$849	10,645,066	SEC↗
Schneid Yair	10% Owner	P Buy	2024-04-18	2024-05-01	100,000	$0.19	$19.0K	10,293,221	SEC↗
Schneid Yair	10% Owner	P Buy	2024-04-18	2024-05-01	17,211	$0.19	$3.3K	10,193,221	SEC↗
Schneid Yair	10% Owner	P Buy	2024-04-18	2024-05-01	74,202	$0.20	$14.8K	10,723,610	SEC↗
Schneid Yair	10% Owner	P Buy	2024-04-18	2024-05-01	4,342	$0.20	$868	10,649,408	SEC↗
Schneid Yair	10% Owner	P Buy	2024-04-18	2024-05-01	100,000	$0.20	$20.0K	10,393,221	SEC↗
Schneid Yair	10% Owner	P Buy	2024-04-18	2024-05-01	247,600	$0.20	$49.5K	10,640,821	SEC↗
Schneid Yair	10% Owner	P Buy	2024-04-17	2024-05-01	453,988	$0.24	$109.0K	10,176,010	SEC↗
Schneid Yair	10% Owner	P Buy	2024-04-17	2024-05-01	551,217	$0.23	$126.8K	9,722,022	SEC↗
Schneid Yair	10% Owner	P Buy	2024-04-17	2024-05-01	243,100	$0.22	$53.5K	9,170,805	SEC↗
Schneid Yair	10% Owner	P Buy	2024-04-17	2024-05-01	50,000	$0.21	$10.5K	8,927,705	SEC↗
Schneid Yair	10% Owner	P Buy	2024-04-17	2024-05-01	50,000	$0.21	$10.5K	8,877,705	SEC↗
Schneid Yair	10% Owner	P Buy	2024-04-17	2024-05-01	56,900	$0.21	$11.9K	8,827,705	SEC↗
Schneid Yair	10% Owner	P Buy	2024-04-17	2024-05-01	241,028	$0.20	$48.2K	8,770,805	SEC↗
Schneid Yair	10% Owner	P Buy	2024-04-17	2024-05-01	68,424	$0.20	$13.7K	8,529,777	SEC↗
Schneid Yair	10% Owner	P Buy	2024-04-17	2024-05-01	100,000	$0.19	$19.0K	8,461,353	SEC↗
Schneid Yair	10% Owner	P Buy	2024-02-08	2024-02-26	150,000	$0.17	$25.5K	8,043,203	SEC↗
Schneid Yair	10% Owner	P Buy	2024-02-07	2024-02-26	25,000	$0.17	$4.3K	7,743,203	SEC↗
Schneid Yair	10% Owner	P Buy	2024-02-07	2024-02-26	150,000	$0.17	$25.5K	7,893,203	SEC↗
Schneid Yair	10% Owner	P Buy	2024-02-06	2024-02-26	25,000	$0.20	$5.0K	7,718,203	SEC↗
Schneid Yair	10% Owner	P Buy	2024-02-05	2024-02-26	97,402	$0.18	$17.5K	7,693,203	SEC↗
Schneid Yair	10% Owner	P Buy	2024-01-30	2024-02-26	335,000	$0.18	$60.3K	7,595,801	SEC↗
Schneid Yair	10% Owner	P Buy	2024-01-29	2024-02-26	150,000	$0.18	$27.0K	7,260,801	SEC↗
West Linda	Director	A Award deriv	2023-07-01	2023-07-05	23,382	—	$0	23,382	SEC↗
Alleva Lawrence M	Director	A Award deriv	2023-07-01	2023-07-05	22,762	—	$0	22,762	SEC↗
Alleva Lawrence M	Director	A Award deriv	2023-06-14	2023-06-16	48,000	—	$0	48,000	SEC↗
Cunningham Emmett	Director	A Award deriv	2023-06-14	2023-06-16	48,000	—	$0	0	SEC↗
LOKAY KEVIN G	Director	A Award deriv	2023-06-14	2023-06-16	48,000	—	$0	48,000	SEC↗
West Linda	Director	A Award deriv	2023-06-14	2023-06-16	48,000	—	$0	48,000	SEC↗
POWELL MICHAEL	Director	A Award deriv	2023-06-14	2023-06-16	64,000	—	$0	64,000	SEC↗
Bachleda Mark	Chief Commercial Officer	P Buy	2023-03-16	2023-03-20	11,000	$2.25	$24.8K	11,000	SEC↗
Degnan Chris	Chief Financial Officer	P Buy	2023-03-13	2023-03-14	10,000	$1.96	$19.6K	10,000	SEC↗
Sorensen Mel	President and CEO	P Buy	2023-03-10	2023-03-14	100,000	$1.68	$168.0K	332,044	SEC↗
Stacey Jennifer Evans	See Remarks	A Award deriv	2023-02-25	2023-02-28	135,000	—	$0	135,000	SEC↗
Bachleda Mark	Chief Commercial Officer	A Award deriv	2023-02-25	2023-02-28	135,000	—	$0	135,000	SEC↗
Kennedy Eugene P.	Chief Medical Officer	A Award deriv	2023-02-25	2023-02-28	55,000	—	$0	55,000	SEC↗
Degnan Chris	Chief Financial Officer	A Award deriv	2023-02-25	2023-02-28	185,000	—	$0	185,000	SEC↗
Sorensen Mel	President and CEO	A Award deriv	2023-02-25	2023-02-28	440,000	—	$0	440,000	SEC↗
Beardsley Robert A	Chief Operating Officer	A Award deriv	2023-02-25	2023-02-28	135,000	—	$0	135,000	SEC↗
Beardsley Robert A	Chief Operating Officer	M Exercise deriv	2022-11-21	2022-11-22	10,000	—	$0	75,651	SEC↗
Beardsley Robert A	Chief Operating Officer	M Exercise	2022-11-21	2022-11-22	10,000	$1.07	$10.7K	108,191	SEC↗
Beardsley Robert A	Chief Operating Officer	M Exercise deriv	2022-09-12	2022-09-13	10,000	—	$0	85,651	SEC↗
Beardsley Robert A	Chief Operating Officer	M Exercise	2022-09-12	2022-09-13	10,000	$1.07	$10.7K	98,191	SEC↗
Kennedy Eugene P.	Chief Medical Officer	A Award deriv	2022-09-01	2022-09-02	150,000	—	$0	150,000	SEC↗
Alleva Lawrence M	Director	G Gift	2022-07-18	2022-07-20	4,000	—	$0	2,325	SEC↗
West Linda	Director	A Award deriv	2022-07-01	2022-07-05	58,496	—	$0	58,496	SEC↗
Cunningham Emmett	Director	A Award deriv	2022-06-15	2022-06-16	15,000	—	$0	0	SEC↗
POWELL MICHAEL	Director	A Award deriv	2022-06-15	2022-06-16	20,000	—	$0	20,000	SEC↗
West Linda	Director	A Award deriv	2022-06-15	2022-06-16	15,000	—	$0	15,000	SEC↗
Alleva Lawrence M	Director	A Award deriv	2022-06-15	2022-06-16	15,000	—	$0	15,000	SEC↗
LOKAY KEVIN G	Director	A Award deriv	2022-06-15	2022-06-16	15,000	—	$0	15,000	SEC↗
Sorensen Mel	President and CEO	A Award deriv	2022-02-28	2022-03-02	264,400	—	$0	264,400	SEC↗
Bachleda Mark	Chief Commercial Officer	A Award deriv	2022-02-28	2022-03-02	75,000	—	$0	75,000	SEC↗
HOLMLUND JON T	Chief Medical Officer	A Award deriv	2022-02-28	2022-03-02	75,000	—	$0	75,000	SEC↗
Stacey Jennifer Evans	See Remarks	A Award deriv	2022-02-28	2022-03-02	75,000	—	$0	75,000	SEC↗
Degnan Chris	Chief Financial Officer	A Award deriv	2022-02-28	2022-03-02	135,000	—	$0	135,000	SEC↗
Beardsley Robert A	Chief Operating Officer	A Award deriv	2022-02-28	2022-03-02	75,000	—	$0	75,000	SEC↗
Beardsley Robert A	Chief Operating Officer	M Exercise deriv	2021-12-17	2021-12-20	20,000	—	$0	95,651	SEC↗
Beardsley Robert A	Chief Operating Officer	M Exercise	2021-12-17	2021-12-20	20,000	$1.07	$21.4K	88,191	SEC↗
West Linda	Director	P Buy	2021-12-17	2021-12-20	20,000	$2.74	$54.8K	60,000	SEC↗
Stacey Jennifer Evans	See Remarks	A Award deriv	2021-10-08	2021-10-12	130,000	—	$0	130,000	SEC↗
Bachleda Mark	Chief Commercial Officer	A Award deriv	2021-10-08	2021-10-12	200,000	—	$0	200,000	SEC↗
HOLMLUND JON T	Chief Medical Officer	M Exercise deriv	2021-09-01	2021-09-03	47,756	—	$0	61,142	SEC↗
HOLMLUND JON T	Chief Medical Officer	M Exercise	2021-09-01	2021-09-03	47,756	$2.43	$116.0K	47,756	SEC↗
HOLMLUND JON T	Chief Medical Officer	S Sale	2021-09-01	2021-09-03	47,756	$8.47	$404.5K	0	SEC↗
Cunningham Emmett	Director	A Award deriv	2021-07-01	2021-07-06	5,408	—	$0	0	SEC↗
Alleva Lawrence M	Director	A Award deriv	2021-07-01	2021-07-06	8,498	—	$0	8,498	SEC↗
West Linda	Director	A Award deriv	2021-07-01	2021-07-06	8,730	—	$0	8,730	SEC↗
Cunningham Emmett	Director	A Award deriv	2021-06-16	2021-06-17	9,888	—	$0	0	SEC↗
POWELL MICHAEL	Director	A Award deriv	2021-06-16	2021-06-17	13,179	—	$0	13,179	SEC↗
West Linda	Director	A Award deriv	2021-06-16	2021-06-17	9,888	—	$0	9,888	SEC↗
Alleva Lawrence M	Director	A Award deriv	2021-06-16	2021-06-17	9,888	—	$0	9,888	SEC↗
LOKAY KEVIN G	Director	A Award deriv	2021-06-16	2021-06-17	9,888	—	$0	9,888	SEC↗
West Linda	Director	P Buy	2021-06-15	2021-06-17	10,000	$9.13	$91.3K	40,000	SEC↗
West Linda	Director	P Buy	2021-06-02	2021-06-04	10,000	$8.65	$86.5K	30,000	SEC↗
West Linda	Director	P Buy	2021-06-01	2021-06-02	10,000	$8.64	$86.4K	20,000	SEC↗
Alleva Lawrence M	Director	P Buy	2021-06-01	2021-06-03	4,045	$8.59	$34.7K	4,045	SEC↗
West Linda	Director	P Buy	2021-05-28	2021-06-02	10,000	$8.64	$86.4K	10,000	SEC↗
Sorensen Mel	President and CEO	M Exercise deriv	2021-03-26	2021-03-30	46,940	—	$0	0	SEC↗
Sorensen Mel	President and CEO	M Exercise deriv	2021-03-26	2021-03-30	170,075	—	$0	0	SEC↗
Sorensen Mel	President and CEO	M Exercise	2021-03-26	2021-03-30	46,940	$1.14	$53.5K	232,044	SEC↗
Sorensen Mel	President and CEO	M Exercise	2021-03-26	2021-03-30	170,075	$1.07	$182.0K	185,104	SEC↗
Novo Holdings A/S	10% Owner	S Sale	2021-02-18	2021-02-19	500,000	$10.58	$5.29M	2,459,021	SEC↗
Sorensen Mel	President and CEO	A Award deriv	2021-01-26	2021-01-28	190,000	—	$0	190,000	SEC↗
Fratamico Arthur	Chief Business Officer	A Award deriv	2021-01-26	2021-01-28	75,000	—	$0	75,000	SEC↗
HOLMLUND JON T	Chief Medical Officer	A Award deriv	2021-01-26	2021-01-28	71,250	—	$0	71,250	SEC↗
Beardsley Robert A	Chief Operating Officer	A Award deriv	2021-01-26	2021-01-28	75,000	—	$0	75,000	SEC↗
Sussman Joel F.	Chief Accounting Officer	A Award deriv	2021-01-26	2021-01-28	50,000	—	$0	50,000	SEC↗
Degnan Chris	Chief Financial Officer	A Award deriv	2021-01-26	2021-01-28	82,500	—	$0	82,500	SEC↗
Sussman Joel F.	Chief Accounting Officer	M Exercise deriv	2020-11-13	2020-11-16	2,639	—	$0	32,238	SEC↗
Sussman Joel F.	Chief Accounting Officer	M Exercise deriv	2020-11-13	2020-11-16	3,755	—	$0	0	SEC↗
Sussman Joel F.	Chief Accounting Officer	M Exercise deriv	2020-11-13	2020-11-16	3,606	—	$0	0	SEC↗
Sussman Joel F.	Chief Accounting Officer	S Sale	2020-11-13	2020-11-16	10,000	$10.32	$103.2K	0	SEC↗
Sussman Joel F.	Chief Accounting Officer	M Exercise	2020-11-13	2020-11-16	3,606	$1.07	$3.9K	3,606	SEC↗
Sussman Joel F.	Chief Accounting Officer	M Exercise	2020-11-13	2020-11-16	3,755	$1.14	$4.3K	7,361	SEC↗
Sussman Joel F.	Chief Accounting Officer	M Exercise	2020-11-13	2020-11-16	2,639	$2.43	$6.4K	10,000	SEC↗
Alleva Lawrence M	Director	P Buy	2020-11-13	2020-11-17	2,325	$10.22	$23.8K	6,325	SEC↗
Sussman Joel F.	Chief Accounting Officer	M Exercise deriv	2020-11-12	2020-11-16	10,000	—	$0	3,606	SEC↗
Sussman Joel F.	Chief Accounting Officer	M Exercise	2020-11-12	2020-11-16	10,000	$1.07	$10.7K	10,000	SEC↗
Sussman Joel F.	Chief Accounting Officer	S Sale	2020-11-12	2020-11-16	10,000	$10.06	$100.6K	0	SEC↗
HOLMLUND JON T	Chief Medical Officer	M Exercise deriv	2020-10-26	2020-10-28	2,244	—	$0	108,898	SEC↗
HOLMLUND JON T	Chief Medical Officer	S Sale	2020-10-26	2020-10-28	2,244	$15.00	$33.7K	0	SEC↗
HOLMLUND JON T	Chief Medical Officer	M Exercise	2020-10-26	2020-10-28	2,244	$2.43	$5.5K	2,244	SEC↗
Novo Holdings A/S	10% Owner	S Sale	2020-10-15	2020-10-19	450,000	$11.00	$4.95M	2,959,021	SEC↗
HOLMLUND JON T	Chief Medical Officer	M Exercise deriv	2020-10-06	2020-10-07	4,904	—	$0	0	SEC↗
HOLMLUND JON T	Chief Medical Officer	M Exercise deriv	2020-10-06	2020-10-07	5,632	—	$0	0	SEC↗
HOLMLUND JON T	Chief Medical Officer	S Sale	2020-10-06	2020-10-07	10,536	$12.00	$126.4K	0	SEC↗
HOLMLUND JON T	Chief Medical Officer	M Exercise	2020-10-06	2020-10-07	5,632	$1.14	$6.4K	5,632	SEC↗
HOLMLUND JON T	Chief Medical Officer	M Exercise	2020-10-06	2020-10-07	4,904	$1.07	$5.2K	4,904	SEC↗
HOLMLUND JON T	Chief Medical Officer	M Exercise deriv	2020-10-05	2020-10-07	100	—	$0	4,904	SEC↗
HOLMLUND JON T	Chief Medical Officer	M Exercise	2020-10-05	2020-10-07	100	$1.07	$107	100	SEC↗
HOLMLUND JON T	Chief Medical Officer	S Sale	2020-10-05	2020-10-07	100	$12.00	$1.2K	0	SEC↗
Novartis Bioventures Ltd	Other	S Sale	2020-06-19	2020-06-22	1,001,312	$8.25	$8.26M	2,467,961	SEC↗
Novartis Bioventures Ltd	Other	S Sale	2020-06-18	2020-06-22	900	$9.04	$8.1K	3,469,273	SEC↗
NOVARTIS AG	10% Owner	S Sale	2020-06-17	2020-06-17	4,622	$9.27	$42.8K	3,470,173	SEC↗
NOVARTIS AG	10% Owner	S Sale	2020-06-16	2020-06-17	8,600	$9.30	$80.0K	3,474,795	SEC↗
NOVARTIS AG	10% Owner	S Sale	2020-06-15	2020-06-17	6,164	$9.05	$55.8K	3,483,395	SEC↗
NOVARTIS AG	10% Owner	S Sale	2020-06-12	2020-06-12	1,500	$9.19	$13.8K	3,489,559	SEC↗
NOVARTIS AG	10% Owner	S Sale	2020-06-11	2020-06-12	7,200	$9.21	$66.3K	3,491,059	SEC↗
NOVARTIS AG	10% Owner	S Sale	2020-06-10	2020-06-12	8,532	$9.46	$80.7K	3,498,259	SEC↗
LOKAY KEVIN G	Director	A Award deriv	2020-06-09	2020-06-10	9,888	—	$0	9,888	SEC↗
Alleva Lawrence M	Director	A Award deriv	2020-06-09	2020-06-10	9,888	—	$0	9,888	SEC↗
POWELL MICHAEL	Director, 10% Owner	A Award deriv	2020-06-09	2020-06-10	13,179	—	$0	13,179	SEC↗
Cunningham Emmett	Director	A Award deriv	2020-06-09	2020-06-10	9,888	—	$0	0	SEC↗
Novartis Bioventures Ltd	10% Owner	S Sale	2020-06-09	2020-06-09	7,000	$9.38	$65.7K	3,506,791	SEC↗
Novartis Bioventures Ltd	10% Owner	S Sale	2020-06-08	2020-06-09	5,659	$9.66	$54.7K	3,513,791	SEC↗
Novartis Bioventures Ltd	10% Owner	S Sale	2020-06-05	2020-06-09	8,652	$9.66	$83.6K	3,519,450	SEC↗
Novartis Bioventures Ltd	10% Owner	S Sale	2020-06-04	2020-06-04	4,088	$9.55	$39.0K	3,528,102	SEC↗
Novartis Bioventures Ltd	10% Owner	S Sale	2020-06-03	2020-06-04	5,208	$9.78	$50.9K	3,532,190	SEC↗
Novartis Bioventures Ltd	10% Owner	S Sale	2020-06-02	2020-06-04	5,669	$9.68	$54.9K	3,537,398	SEC↗
HOLMLUND JON T	Chief Medical Officer	M Exercise deriv	2020-05-26	2020-05-28	692	—	$0	5,004	SEC↗
HOLMLUND JON T	Chief Medical Officer	M Exercise	2020-05-26	2020-05-28	692	$1.07	$740	692	SEC↗
HOLMLUND JON T	Chief Medical Officer	S Sale	2020-05-26	2020-05-28	692	$12.00	$8.3K	0	SEC↗
HOLMLUND JON T	Chief Medical Officer	M Exercise deriv	2020-05-21	2020-05-22	1,174	—	$0	5,696	SEC↗
HOLMLUND JON T	Chief Medical Officer	M Exercise	2020-05-21	2020-05-22	1,174	$1.07	$1.3K	1,174	SEC↗
HOLMLUND JON T	Chief Medical Officer	S Sale	2020-05-21	2020-05-22	1,174	$12.00	$14.1K	0	SEC↗
HOLMLUND JON T	Chief Medical Officer	M Exercise deriv	2020-05-20	2020-05-22	969	—	$0	6,870	SEC↗
HOLMLUND JON T	Chief Medical Officer	S Sale	2020-05-20	2020-05-22	969	$12.00	$11.6K	0	SEC↗
HOLMLUND JON T	Chief Medical Officer	M Exercise	2020-05-20	2020-05-22	969	$1.07	$1.0K	969	SEC↗
HOLMLUND JON T	Chief Medical Officer	M Exercise deriv	2020-05-12	2020-05-12	671	—	$0	7,839	SEC↗
HOLMLUND JON T	Chief Medical Officer	M Exercise	2020-05-12	2020-05-12	671	$1.07	$718	671	SEC↗
HOLMLUND JON T	Chief Medical Officer	S Sale	2020-05-12	2020-05-12	671	$12.00	$8.1K	0	SEC↗
HOLMLUND JON T	Chief Medical Officer	M Exercise deriv	2020-05-11	2020-05-12	185	—	$0	8,510	SEC↗
HOLMLUND JON T	Chief Medical Officer	M Exercise	2020-05-11	2020-05-12	185	$1.07	$198	185	SEC↗
HOLMLUND JON T	Chief Medical Officer	S Sale	2020-05-11	2020-05-12	185	$12.00	$2.2K	0	SEC↗
HOLMLUND JON T	Chief Medical Officer	M Exercise deriv	2020-05-08	2020-05-12	5,102	—	$0	8,695	SEC↗
HOLMLUND JON T	Chief Medical Officer	S Sale	2020-05-08	2020-05-12	5,102	$12.00	$61.2K	0	SEC↗
HOLMLUND JON T	Chief Medical Officer	M Exercise	2020-05-08	2020-05-12	5,102	$1.07	$5.5K	5,102	SEC↗
HOLMLUND JON T	Chief Medical Officer	M Exercise deriv	2020-05-07	2020-05-07	2,059	—	$0	13,797	SEC↗
HOLMLUND JON T	Chief Medical Officer	S Sale	2020-05-07	2020-05-07	2,059	$12.00	$24.7K	0	SEC↗
HOLMLUND JON T	Chief Medical Officer	M Exercise	2020-05-07	2020-05-07	2,059	$1.07	$2.2K	2,059	SEC↗
HOLMLUND JON T	Chief Medical Officer	M Exercise deriv	2020-05-06	2020-05-07	1,489	—	$0	15,856	SEC↗
HOLMLUND JON T	Chief Medical Officer	M Exercise	2020-05-06	2020-05-07	1,489	$1.07	$1.6K	1,489	SEC↗
HOLMLUND JON T	Chief Medical Officer	S Sale	2020-05-06	2020-05-07	1,489	$12.00	$17.9K	0	SEC↗
HOLMLUND JON T	Chief Medical Officer	M Exercise deriv	2020-05-05	2020-05-07	3,064	—	$0	17,345	SEC↗
HOLMLUND JON T	Chief Medical Officer	S Sale	2020-05-05	2020-05-07	3,064	$12.16	$37.3K	0	SEC↗
HOLMLUND JON T	Chief Medical Officer	M Exercise	2020-05-05	2020-05-07	3,064	$1.07	$3.3K	3,064	SEC↗
West Linda	Director	A Award deriv	2020-03-31	2020-04-02	19,776	—	$0	19,776	SEC↗
Beardsley Robert A	Chief Operating Officer	A Award deriv	2020-01-31	2020-02-04	74,435	—	$0	74,435	SEC↗
Riley Dennis	Chief Scientific Officer	A Award deriv	2020-01-31	2020-02-04	74,435	—	$0	74,435	SEC↗
Sorensen Mel	President and CEO	A Award deriv	2020-01-31	2020-02-04	186,087	—	$0	186,087	SEC↗
Degnan Chris	Chief Financial Officer	A Award deriv	2020-01-31	2020-02-04	74,435	—	$0	74,435	SEC↗
Fratamico Arthur	Chief Business Officer	A Award deriv	2020-01-31	2020-02-04	74,435	—	$0	74,435	SEC↗
Sussman Joel F.	Chief Accounting Officer	A Award deriv	2020-01-31	2020-02-04	49,263	—	$0	49,623	SEC↗
HOLMLUND JON T	Chief Medical Officer	A Award deriv	2020-01-31	2020-02-04	74,435	—	$0	74,435	SEC↗
Alleva Lawrence M	Director	P Buy	2019-12-13	2019-12-17	4,000	$9.78	$39.1K	4,000	SEC↗
Beardsley Robert A	Chief Operating Officer	C Conversion deriv	2019-11-12	2019-11-12	6,774	—	$0	0	SEC↗
Beardsley Robert A	Chief Operating Officer	C Conversion deriv	2019-11-12	2019-11-12	2,000	—	$0	0	SEC↗
Beardsley Robert A	Chief Operating Officer	C Conversion deriv	2019-11-12	2019-11-12	68,907	—	$0	0	SEC↗
NOVARTIS AG	10% Owner	C Conversion deriv	2019-11-12	2019-11-12	7,200,000	—	$0	0	SEC↗
NOVARTIS AG	10% Owner	C Conversion deriv	2019-11-12	2019-11-12	451,609	—	$0	0	SEC↗
NOVARTIS AG	10% Owner	C Conversion deriv	2019-11-12	2019-11-12	9,000,000	—	$0	0	SEC↗
HEALY JAMES	10% Owner	C Conversion deriv	2019-11-12	2019-11-12	9,090,909	—	$0	0	SEC↗
HEALY JAMES	10% Owner	C Conversion deriv	2019-11-12	2019-11-12	2,709,659	—	$0	0	SEC↗
MOTT DAVID M	10% Owner	C Conversion deriv	2019-11-12	2019-11-12	9,600,000	—	$0	0	SEC↗
MOTT DAVID M	10% Owner	C Conversion deriv	2019-11-12	2019-11-12	1,354,829	—	$0	0	SEC↗
MOTT DAVID M	10% Owner	C Conversion deriv	2019-11-12	2019-11-12	8,975,000	—	$0	0	SEC↗
Novo Holdings A/S	10% Owner	C Conversion deriv	2019-11-12	2019-11-14	2,709,659	—	$0	0	SEC↗
Novo Holdings A/S	10% Owner	C Conversion deriv	2019-11-12	2019-11-14	12,000,000	—	$0	0	SEC↗
Blackstone Holdings II L.P.	10% Owner	C Conversion deriv	2019-11-12	2019-11-14	561,385	—	$0	0	SEC↗
Blackstone Holdings II L.P.	10% Owner	C Conversion deriv	2019-11-12	2019-11-14	2,334,966	—	$0	0	SEC↗
Blackstone Holdings II L.P.	10% Owner	C Conversion deriv	2019-11-12	2019-11-14	1,552,035	—	$0	0	SEC↗
Blackstone Holdings II L.P.	10% Owner	C Conversion deriv	2019-11-12	2019-11-14	2,807,372	—	$0	0	SEC↗
Clarus IV-B, L.P.	10% Owner	C Conversion deriv	2019-11-12	2019-11-14	561,385	—	$0	0	SEC↗
Clarus IV-B, L.P.	10% Owner	C Conversion deriv	2019-11-12	2019-11-14	2,807,372	—	$0	0	SEC↗
Clarus IV-B, L.P.	10% Owner	C Conversion deriv	2019-11-12	2019-11-14	1,552,035	—	$0	0	SEC↗
Clarus IV-B, L.P.	10% Owner	C Conversion deriv	2019-11-12	2019-11-14	2,334,966	—	$0	0	SEC↗
Beardsley Robert A	Chief Operating Officer	C Conversion	2019-11-12	2019-11-12	15,361	—	$0	68,191	SEC↗
NOVARTIS AG	10% Owner	P Buy	2019-11-12	2019-11-12	250,000	$12.00	$3.00M	3,543,067	SEC↗
NOVARTIS AG	10% Owner	C Conversion	2019-11-12	2019-11-12	3,293,067	—	$0	3,293,067	SEC↗
HEALY JAMES	10% Owner	P Buy	2019-11-12	2019-11-12	750,000	$12.00	$9.00M	3,083,712	SEC↗
HEALY JAMES	10% Owner	C Conversion	2019-11-12	2019-11-12	2,333,712	—	$0	2,333,712	SEC↗
MOTT DAVID M	10% Owner	C Conversion	2019-11-12	2019-11-12	267,935	—	$0	3,941,381	SEC↗
MOTT DAVID M	10% Owner	C Conversion	2019-11-12	2019-11-12	1,774,922	—	$0	1,774,922	SEC↗
MOTT DAVID M	10% Owner	C Conversion	2019-11-12	2019-11-12	1,898,524	—	$0	3,673,446	SEC↗
MOTT DAVID M	10% Owner	P Buy	2019-11-12	2019-11-12	416,666	$12.00	$5.00M	4,358,047	SEC↗
Novo Holdings A/S	10% Owner	C Conversion	2019-11-12	2019-11-14	535,869	—	$0	2,909,021	SEC↗
Novo Holdings A/S	10% Owner	C Conversion	2019-11-12	2019-11-14	2,373,152	—	$0	2,373,152	SEC↗
Novo Holdings A/S	10% Owner	P Buy	2019-11-12	2019-11-14	500,000	$12.00	$6.00M	3,409,021	SEC↗
Blackstone Holdings II L.P.	10% Owner	C Conversion	2019-11-12	2019-11-14	301,001	—	$0	301,001	SEC↗
Blackstone Holdings II L.P.	10% Owner	C Conversion	2019-11-12	2019-11-14	461,769	—	$0	461,769	SEC↗
Blackstone Holdings II L.P.	10% Owner	C Conversion	2019-11-12	2019-11-14	555,193	—	$0	555,193	SEC↗
Blackstone Holdings II L.P.	10% Owner	C Conversion	2019-11-12	2019-11-14	111,021	—	$0	111,021	SEC↗
Blackstone Holdings II L.P.	10% Owner	P Buy	2019-11-12	2019-11-14	80,786	$12.00	$969.4K	542,555	SEC↗
Blackstone Holdings II L.P.	10% Owner	P Buy	2019-11-12	2019-11-14	52,660	$12.00	$631.9K	353,661	SEC↗
Blackstone Holdings II L.P.	10% Owner	P Buy	2019-11-12	2019-11-14	97,131	$12.00	$1.17M	652,324	SEC↗
Blackstone Holdings II L.P.	10% Owner	P Buy	2019-11-12	2019-11-14	19,423	$12.00	$233.1K	130,444	SEC↗
Clarus IV-B, L.P.	10% Owner	C Conversion	2019-11-12	2019-11-14	555,193	—	$0	555,193	SEC↗
Clarus IV-B, L.P.	10% Owner	P Buy	2019-11-12	2019-11-14	19,423	$12.00	$233.1K	130,444	SEC↗
Clarus IV-B, L.P.	10% Owner	P Buy	2019-11-12	2019-11-14	97,131	$12.00	$1.17M	652,324	SEC↗
Clarus IV-B, L.P.	10% Owner	P Buy	2019-11-12	2019-11-14	52,660	$12.00	$631.9K	353,661	SEC↗
Clarus IV-B, L.P.	10% Owner	P Buy	2019-11-12	2019-11-14	80,786	$12.00	$969.4K	542,555	SEC↗
Clarus IV-B, L.P.	10% Owner	C Conversion	2019-11-12	2019-11-14	111,021	—	$0	111,021	SEC↗
Clarus IV-B, L.P.	10% Owner	C Conversion	2019-11-12	2019-11-14	461,769	—	$0	461,769	SEC↗
Clarus IV-B, L.P.	10% Owner	C Conversion	2019-11-12	2019-11-14	301,001	—	$0	301,001	SEC↗
Degnan Chris	Chief Financial Officer	A Award deriv	2019-11-06	2019-11-08	229,513	—	$0	229,513	SEC↗
POWELL MICHAEL	Director, 10% Owner	A Award deriv	2019-11-06	2019-11-08	19,776	—	$0	19,776	SEC↗
Cunningham Emmett	Director	A Award deriv	2019-11-06	2019-11-08	19,776	—	$0	0	SEC↗
Blackstone Group Management L.	10% Owner	J Other deriv	2019-11-06	2019-11-08	19,776	—	$0	0	SEC↗
Fuller Jason	Director	A Award deriv	2019-11-06	2019-11-08	19,776	—	$0	19,776	SEC↗
Schneid Yair	10% Owner	P Buy	2014-04-17	2024-05-01	318,150	$0.19	$60.4K	8,361,353	SEC↗